Jazz Pharmaceuticals plc
JAZZ
$229.63
$0.440.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 293.10M | 203.45M | 251.41M | -718.47M | -92.50M |
| Total Depreciation and Amortization | 181.40M | 179.17M | 178.25M | 174.01M | 164.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.20M | 52.64M | -85.89M | 960.43M | 69.70M |
| Change in Net Operating Assets | -12.10M | -72.74M | 130.85M | -327.12M | 287.80M |
| Cash from Operations | 408.20M | 362.52M | 474.62M | 88.86M | 429.80M |
| Capital Expenditure | -19.70M | -16.73M | -15.18M | -12.97M | -13.90M |
| Sale of Property, Plant, and Equipment | -- | 28.17M | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | -858.05M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 142.80M | -383.60M | -312.63M | 230.00M | -155.10M |
| Cash from Investing | 123.10M | -372.16M | -327.80M | -641.02M | -169.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.80M | -7.75M | -7.75M | -7.75M | -757.80M |
| Issuance of Common Stock | 32.90M | 85.19M | 733.00K | 10.50M | 11.50M |
| Repurchase of Common Stock | -103.60M | -2.00M | -3.81M | -127.27M | -67.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -78.50M | 75.44M | -10.83M | -124.53M | -813.50M |
| Foreign Exchange rate Adjustments | -400.00K | 33.00K | 203.00K | 4.62M | 1.70M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 452.40M | 65.83M | 136.19M | -672.07M | -551.00M |